CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Lian Brian President & CEO | Sale | −53,279 | $33.38 | $1.8M | 2,546,967 |
| 2026-01-05 | Lian Brian President & CEO | Sale | −41,276 | $34.22 | $1.4M | 2,505,691 |
| 2026-01-05 | Lian Brian President & CEO | Sale | −6,400 | $35.07 | $224K | 2,499,291 |
| 2026-01-02 | ZANTE GREG Chief Financial Officer | Grant or award | +41,000 | 215,483 | ||
| 2026-01-02 | ZANTE GREG Chief Financial Officer | Grant or award | +32,049 | 247,532 | ||
| 2026-01-02 | ZANTE GREG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +91,000 | 91,000 | ||
| 2026-01-02 | Mancini Marianna Chief Operating Officer | Grant or award | +41,000 | 434,802 | ||
| 2026-01-02 | Mancini Marianna Chief Operating Officer | Grant or award | +32,049 | 466,851 | ||
| 2026-01-02 | Mancini Marianna Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +91,000 | 91,000 | ||
| 2026-01-02 | Lian Brian President & CEO | Grant or award | +78,400 | 2,508,620 | ||
| 2026-01-02 | Lian Brian President & CEO | Grant or award | +224,080 | 2,732,700 | ||
| 2026-01-02 | Lian Brian President & CEO | Grant or award · Stock Option (Right to Buy) | +176,300 | 176,300 | ||
| 2026-01-02 | SINGLETON J MATTHEW Director | Grant or award | +3,150 | 12,650 | ||
| 2026-01-02 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-01-02 | MACARTNEY LAWSON Director | Grant or award | +3,150 | 51,115 | ||
| 2026-01-02 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-01-02 | Rowland Charles A Jr Director | Grant or award | +3,150 | 33,150 | ||
| 2026-01-02 | Rowland Charles A Jr Director | Grant or award · Stock Option (Right to Buy) | +20,400 | 20,400 | ||
| 2026-01-02 | FOEHR MATTHEW W Director | Option exercise | +16,000 | $3.33 | $53K | 148,036 |
| 2026-01-02 | FOEHR MATTHEW W Director | Sale | −16,000 | $35.11 | $562K | 132,036 |
Page 2 of 27 · 528 trades